A database of FDA approved therapeutic peptides and proteins
ID1001 | ThPPIDTh1001 | NameLepirudin | Peptide SequenceLVYTDCTESGQNLCLCEGSN Full view | Length65 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandRefludan | CompanyBerlex Labs | Physical AppearanceSterile, white, freeze-dried powder | Route of AdministartionIntravenous infusion | CategoryAntithrombins and Fibrinolytic Agents | TargetProthrombin |
ID1032 | ThPPIDTh1006 | NameBivalirudin | Peptide SequenceFPRPGGGGNGDFEEIPEEYL Full view | Length20 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAngiomax | CompanyMedicines Co or MDCO | Physical AppearanceWhite lyophilized cake in single-use vials | Route of AdministartionIntravenous infusion | CategoryAntithrombins | TargetProthrombin |
ID1033 | ThPPIDTh1006 | NameBivalirudin | Peptide SequenceFPRPGGGGNGDFEEIPEEYL Full view | Length20 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAngiox | CompanyThe Medicines Company UK Ltd | Physical AppearancePowder for concentrate for solution | Route of AdministartionInjection | CategoryAntithrombins | TargetProthrombin |
ID1055 | ThPPIDTh1009 | NameAlteplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandActivase | CompanyGenentech Inc | Physical AppearanceSterile, white to off-white, lyophilized powder | Route of AdministartionIntravenous | CategoryThrombolytic Agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1064 | ThPPIDTh1011 | NameDarbepoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandAranesp | CompanyAmgen Inc | Physical AppearanceSterile, colorless, preservative-free solution containing polysorbate | Route of AdministartionIntravenousor Subcutaneous administration | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1067 | ThPPIDTh1012 | NameReteplase | Peptide SequenceSYQGNSDCYFGNGSAYRGTH Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandRetavase | CompanyCentocor | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionIntravenous Injection | CategoryFibrinolytic Agents, Thrombolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1071 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandBinocrit | CompanySandoz | Physical AppearanceClear colourless solution | Route of AdministartionSubcutaneous and Intravenous infusion | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1072 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpocept | CompanyLupin pharma | Physical AppearanceN.A. | Route of AdministartionInjection | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1073 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpofit | CompanyIntas pharma | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1074 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpogen | CompanyAmgen Inc. | Physical AppearanceSterile, colorless liquid | Route of AdministartionSubcutaneous Injection | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1075 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEpogin | CompanyChugai | Physical AppearanceN.A. | Route of AdministartionSubcutaneous or by Intravenous. | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1076 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandEprex | CompanyJanssen-Cilag. Ortho Biologics LLC | Physical AppearanceSolution | Route of AdministartionSubcutaneous and Intravenous infusion | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1077 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandNanokine | CompanyNanogen Pharmaceutical biotechnology, Vietnam) | Physical AppearanceSterile, white, lyophilized powder. The reconstituted preparation with 1 ml solvent (containing 0.9% benzyl alcohol) results in a clear, colorless solution. | Route of AdministartionInjection | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1078 | ThPPIDTh1013 | NameEpoetin alfa | Peptide SequenceAPPRLICDSRVLERYLLEAK Full view | Length166 | Functional ClassificationIb | DiseaseHematological | BrandProcrit | CompanyOrtho Biotech | Physical AppearanceSterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution | Route of AdministartionIntravenous(IV) or Subcutaneous (SC) administration. | CategoryAnti-anemic Agents, Hematinics | TargetErythropoietin receptor |
ID1148 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAdvate | CompanyN.A. | Physical AppearancePowder form | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1149 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAlphanate | CompanyN.A. | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1150 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandBioclate | CompanyBaxter Healthcare Corporation, Hyland Division and Genetics Institute, Inc. | Physical AppearanceSterile, nonpyrogenic, off-white to faint yellow, lyophilized powder | Route of AdministartionIntravenous infusion | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1151 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandHelixate FS | CompanyN.A. | Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrate | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1152 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandHemofil M | CompanyN.A. | Physical AppearanceDry concentrate | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1153 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandHyate:C | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1154 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandKoate-HP | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1155 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandKogenate FS | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1156 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandMonarc-M | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1157 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandMonoclate-P | CompanyN.A. | Physical AppearanceLyophilized powder for solution | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1158 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandReFacto | CompanyN.A. | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1159 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandXyntha | CompanyN.A. | Physical AppearanceSterile, nonpyrogenic, preservative-free, freeze-dried powder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1201 | ThPPIDTh1026 | NameAnistreplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIc | DiseaseHematological,Metabolic | BrandEminase | CompanyWulfing Pharma GmbH | Physical AppearanceDry powder | Route of AdministartionIntravenous infusion | CategoryThrombolytic Agents, Fibrinolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1210 | ThPPIDTh1028 | NameTenecteplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandTNKase | CompanyGenentech Inc | Physical AppearanceSterile, white to off-white, lyophilized powder | Route of AdministartionIntravenous Injection | CategoryThrombolytic Agents, Fibrinolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1,Plasminogen activator inhibitor 2,Tetranectin,Keratin, type II cytoskeletal 8,Annexin A2,Calreticulin,Calnexin,Prolow-density lipoprotein |
ID1234 | ThPPIDTh1032 | NameCoagulation factor VIIa | Peptide SequenceANAFLEELRPGSLERECKEE Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandNovoSeven | CompanyNovo Nordisk | Physical AppearanceSterile, white lyophilized powder | Route of AdministartionInjection | CategoryThrombotic Agents, Coagulants | TargetCoagulation factor X,Serine protease hepsin,Tissue factor pathway inhibitor,Vitamin K-dependent gamma-carboxylase,Coagulation factor VII,Tissue factor |
ID1288 | ThPPIDTh1042 | NameCollagenase | Peptide SequenceMKRKCLSKRLMLAITMATIF Full view | Length255 | Functional ClassificationIc | DiseaseHematological | BrandCordase | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryN.A. | TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain |
ID1289 | ThPPIDTh1042 | NameCollagenase | Peptide SequenceMKRKCLSKRLMLAITMATIF Full view | Length255 | Functional ClassificationIc | DiseaseHematological | BrandSantyl | CompanyAdvance Biofactures Corp | Physical AppearanceSterile enzymatic debriding ointment | Route of AdministartionExternal use only | CategoryN.A. | TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain |
ID1290 | ThPPIDTh1042 | NameCollagenase | Peptide SequenceMKRKCLSKRLMLAITMATIF Full view | Length255 | Functional ClassificationIc | DiseaseHematological | BrandXiaflex | CompanyAuxilium | Physical AppearanceSterile lyophilized powder (white cake) | Route of AdministartionIntralesional Injection | CategoryN.A. | TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain |
ID1361 | ThPPIDTh1051 | NameHuman Serum Albumin | Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view | Length609 | Functional ClassificationIa | DiseaseHematological/Metabolic/genetic | BrandAlbuminar | CompanyCSL Behring | Physical AppearanceSterile aqueous solution of albumin obtained from large pools of adult human venous plasma by low temperature controlled fractionation according to the Cohn process. | Route of AdministartionAlbumin (Human) 25%, Albuminar-25 (albumin human) , is to be administered by the Intravenous route. | CategorySerum substitutes | TargetN.A. |
ID1362 | ThPPIDTh1051 | NameHuman Serum Albumin | Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view | Length609 | Functional ClassificationIa | DiseaseHematological/Metabolic/genetic | BrandAlbutein | CompanyGRIFOLS | Physical AppearanceSterile, aqueous solution for single dose intravenous administration containing 20% human albumin (weight/volume). | Route of AdministartionAlbutein 20% is to be administered by the Intravenous route. | CategorySerum substitutes | TargetN.A. |
ID1363 | ThPPIDTh1052 | NameEptifibatide | Peptide SequenceMpr-Har-Gly-Asp-Trp- Full view | Length7 | Functional ClassificationIb | DiseaseHematological/Metabolic | BrandINTEGRILIN | CompanySchering-Plough/Essex | Physical AppearanceClear, colorless, sterile, non-pyrogenic solution of Eptifibatide | Route of AdministartionInjection Solution for IIntravenousUse | CategoryPlatelet Aggregation Inhibitors | TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor |
ID1365 | ThPPIDTh1053 | NameSerum albumin iodonated | Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view | Length600 | Functional ClassificationIV | DiseaseHematological Disorders | BrandMegatope | CompanyIsoTex Diagnostics | Physical AppearanceColorless to very pale yellow solutions | Route of AdministartionInjection for Intravenous administration | CategoryDiagnostic Agents | TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP |
ID1366 | ThPPIDTh1053 | NameSerum albumin iodonated | Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view | Length600 | Functional ClassificationIV | DiseaseHematological Disorders | BrandJeanotope | CompanyIsoTex Diagnostics | Physical AppearanceSterile, nonpyrogenic, aqueos solution | Route of AdministartionIntravenous infusion | CategoryDiagnostic Agents | TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP |
ID1367 | ThPPIDTh1053 | NameSerum albumin iodonated | Peptide SequenceMKWVTFISLLFLFSSAYSRG Full view | Length600 | Functional ClassificationIV | DiseaseHematological Disorders | BrandVolumex | CompanyIsoTex Diagnostics | Physical AppearanceColorless to very pale yellow. | Route of AdministartionIntravenous infusion | CategoryDiagnostic Agents | TargetApolipoprotein E,Serum amyloid A-1 protein,Protein AMBP |
ID1453 | ThPPIDTh1083 | NameCoagulation Factor Ix | Peptide SequenceYNSGKLEEFVQGNLERECME Full view | Length415 | Functional ClassificationIa | DiseaseHematological/Metabolic/genetic | BrandAlprolix | CompanyBiogen Idec Inc., and Genentech USA, Inc | Physical AppearanceSterile, non-pyrogenic, preservative-free, white to off-white, lyophilized powder to cake for reconstitution with the provided diluent | Route of AdministartionIntravenous infusion | CategoryCoagulants and Thrombotic Agents | TargetN.A. |
ID1475 | ThPPIDTh1095 | NameRanibizumab | Peptide SequenceLight Chain SASQDISN Full view | Length447 | Functional ClassificationIIa | DiseaseHematological/Eye Disorder | BrandLucentis | CompanyGenentech | Physical AppearanceSterile, colorless to pale yellow solution | Route of AdministartionIntravitreal injection | CategoryOphthalmics | TargetVascular endothelial growth factor A |
ID1529 | ThPPIDTh1108 | NamePegaptanib | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIa | DiseaseHematological/Eye Disorder | BrandMacugen | CompanyGilead Sciences | Physical AppearanceSterile, aqueous solution containing pegaptanib sodium for intravitreous injection | Route of AdministartionIntravitreal injection | CategoryIntended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. | TargetN.A. |
ID1549 | ThPPIDTh1118 | NameSulodexide | Peptide SequenceN.A. Full view | Length0 | Functional ClassificationIIIc | DiseaseHormonal/genetic/Hematological/N.A. | BrandSULODEXIDE | CompanySyntex S.A | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryAntithrombins and Fibrinolytic Agents and Hypoglycemic Agents and Anticoagulants and Hypolipidemic Agents | TargetHeparin cofactor 2,Antithrombin-III |
ID1637 | ThPPIDTh1143 | NameFibrinolysin Aka Plasmin | Peptide SequenceFibrinolysin heavy c Full view | Length786 | Functional ClassificationIc | DiseaseHematological | BrandElase | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryN.A. | TargetN.A. |
ID1684 | ThPPIDTh1164 | NameAntithrombin Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandAtryn | CompanyGtc Biotherapeutics, Inc. | Physical AppearanceInjection, Powder, Lyophilized, for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1685 | ThPPIDTh1164 | NameAntithrombin Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandAtryn | CompanyR Evo Bioloigics, Inc. | Physical AppearanceInjection, Powder, Lyophilized, for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1687 | ThPPIDTh1165 | NameAntithrombin III human | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandThrombate III | CompanyGRIFOLS USA, LLC | Physical Appearancekit | Route of AdministartionNA | CategoryNA | TargetNA |
ID1688 | ThPPIDTh1165 | NameAntithrombin III human | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandThrombate III | CompanyGrifols Therapeutics Inc | Physical AppearancePowder for Solution | Route of AdministartionNA | CategoryNA | TargetNA |
ID1691 | ThPPIDTh1165 | NameAntithrombin III human | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandThrombate III Pws IV 1000iu/vial | CompanyMiles Inc. Pharmaceutical Division | Physical AppearancePowder for Solution | Route of AdministartionNA | CategoryNA | TargetNA |
ID1719 | ThPPIDTh1172 | NameCoagulation Factor XIII A-Subunit (Recombinant) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandTretten | CompanyNovo Nordisk | Physical AppearanceKit | Route of AdministartionIntravenous | CategoryNA | TargetNA |
ID1720 | ThPPIDTh1172 | NameCoagulation Factor XIII A-Subunit (Recombinant) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseHematological Disorders | BrandTretten | CompanyNovo Nordisk Canada Inc | Physical AppearancePowder for Solution | Route of AdministartionIntravenous | CategoryNA | TargetNA |